Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

725 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
PRospective Imaging of CErvical cancer and neoadjuvant treatment (PRICE) study: role of ultrasound to predict partial response in locally advanced cervical cancer patients undergoing chemoradiation and radical surgery.
Testa AC, Ferrandina G, Moro F, Pasciuto T, Moruzzi MC, De Blasis I, Mascilini F, Foti E, Autorino R, Collarino A, Gui B, Zannoni GF, Gambacorta MA, Valentini AL, Rufini V, Scambia G. Testa AC, et al. Among authors: autorino r. Ultrasound Obstet Gynecol. 2018 May;51(5):684-695. doi: 10.1002/uog.17551. Ultrasound Obstet Gynecol. 2018. PMID: 28620930 Free article.
Can "early" and "late"18F-FDG PET-CT be used as prognostic factors for the clinical outcome of patients with locally advanced head and neck cancer treated with radio-chemotherapy?
Castaldi P, Rufini V, Bussu F, Miccichè F, Dinapoli N, Autorino R, Lago M, De Corso E, Almadori G, Galli J, Paludetti G, Giordano A, Valentini V. Castaldi P, et al. Among authors: autorino r. Radiother Oncol. 2012 Apr;103(1):63-8. doi: 10.1016/j.radonc.2012.03.001. Epub 2012 Mar 27. Radiother Oncol. 2012. PMID: 22459579
HPV infection in squamous cell carcinomas arising from different mucosal sites of the head and neck region. Is p16 immunohistochemistry a reliable surrogate marker?
Bussu F, Sali M, Gallus R, Vellone VG, Zannoni GF, Autorino R, Dinapoli N, Santangelo R, Martucci R, Graziani C, Miccichè F, Almadori G, Galli J, Delogu G, Sanguinetti M, Rindi G, Valentini V, Paludetti G. Bussu F, et al. Among authors: autorino r. Br J Cancer. 2013 Mar 19;108(5):1157-62. doi: 10.1038/bjc.2013.55. Epub 2013 Feb 12. Br J Cancer. 2013. PMID: 23403821 Free PMC article.
Human papillomavirus (HPV) infection in squamous cell carcinomas arising from the oropharynx: detection of HPV DNA and p16 immunohistochemistry as diagnostic and prognostic indicators--a pilot study.
Bussu F, Sali M, Gallus R, Petrone G, Zannoni GF, Autorino R, Dinapoli N, Santangelo R, Vellone VG, Graziani C, Miccichè F, Almadori G, Galli J, Delogu G, Sanguinetti M, Rindi G, Tommasino M, Valentini V, Paludetti G. Bussu F, et al. Among authors: autorino r. Int J Radiat Oncol Biol Phys. 2014 Aug 1;89(5):1115-1120. doi: 10.1016/j.ijrobp.2014.04.044. Epub 2014 Jul 8. Int J Radiat Oncol Biol Phys. 2014. PMID: 25035216
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study.
Ferrandina G, Gambacorta A, Gallotta V, Smaniotto D, Fagotti A, Tagliaferri L, Foti E, Fanfani F, Autorino R, Scambia G, Valentini V. Ferrandina G, et al. Among authors: autorino r. Int J Radiat Oncol Biol Phys. 2014 Nov 15;90(4):778-85. doi: 10.1016/j.ijrobp.2014.07.033. Epub 2014 Oct 18. Int J Radiat Oncol Biol Phys. 2014. PMID: 25585781 Clinical Trial.
MITHRA - multiparametric MR/CT image adapted brachytherapy (MR/CT-IABT) in anal canal cancer: a feasibility study.
Tagliaferri L, Manfrida S, Barbaro B, Colangione MM, Masiello V, Mattiucci GC, Placidi E, Autorino R, Gambacorta MA, Chiesa S, Mantini G, Kovács G, Valentini V. Tagliaferri L, et al. Among authors: autorino r. J Contemp Brachytherapy. 2015 Oct;7(5):336-45. doi: 10.5114/jcb.2015.55118. Epub 2015 Oct 19. J Contemp Brachytherapy. 2015. PMID: 26622238 Free PMC article.
Low-dose radiotherapy and concurrent FOLFIRI-bevacizumab: a Phase II study.
Morganti AG, Cellini F, Mignogna S, Padula GD, Caravatta L, Deodato F, Picardi V, Macchia G, Cilla S, Buwenge M, Di Lullo L, Gambacorta MA, Balducci M, Mattiucci GC, Autorino R, Valentini V. Morganti AG, et al. Among authors: autorino r. Future Oncol. 2016 Mar;12(6):779-87. doi: 10.2217/fon.15.350. Epub 2016 Feb 1. Future Oncol. 2016. PMID: 26829128 Clinical Trial.
Simultaneous Integrated Boost Volumetric Modulated Arc Therapy in the Postoperative Treatment of High-Risk to Intermediate-Risk Endometrial Cancer: Results of ADA II Phase 1-2 Trial.
Macchia G, Cilla S, Deodato F, Ianiro A, Legge F, Marucci M, Cammelli S, Perrone AM, De Iaco P, Gambacorta MA, Autorino R, Valentini V, Morganti AG, Ferrandina G. Macchia G, et al. Among authors: autorino r. Int J Radiat Oncol Biol Phys. 2016 Nov 1;96(3):606-13. doi: 10.1016/j.ijrobp.2016.07.004. Epub 2016 Jul 15. Int J Radiat Oncol Biol Phys. 2016. PMID: 27681755 Clinical Trial.
725 results